<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03364257</url>
  </required_header>
  <id_info>
    <org_study_id>PTQ-02</org_study_id>
    <nct_id>NCT03364257</nct_id>
  </id_info>
  <brief_title>iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients</brief_title>
  <acronym>IDENTIFY</acronym>
  <official_title>National, Single-arm Clinical Study on iDTECT™ Blood Performance to Identify Viral or Bacterial Pathogens in Febrile Neutropenic Patients With Suspected Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pathoquest</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pathoquest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multicentre French observational study assessing the performance and
      medico-economic utility of iDTECT Blood versus conventional microbiologic diagnosis in
      patients with febrile neutropenia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Febrile neutropenic patients suspected of sepsis will follow the conventional infectious
      diagnosis work-up over the entire observation period, and will be tested in addition with
      iDTECT Blood on Study Day 1.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of detection of clinically relevant bacterial or viral pathogen (CRBV) by iDTECT™ Blood as compared to conventional microbiological methods at inclusion</measure>
    <time_frame>7 months</time_frame>
    <description>Sensitivity, specificity, negative predictive value, positive predictive value at inclusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Antiobiotic use</measure>
    <time_frame>9 months</time_frame>
    <description>Type of antibiotic, duration of antibiotic course</description>
  </secondary_outcome>
  <enrollment type="Anticipated">97</enrollment>
  <condition>Febrile Neutropenia</condition>
  <condition>Acute Leukemia</condition>
  <condition>Stem Cell Transplantation</condition>
  <condition>Infection</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>iDTECT Blood</intervention_name>
    <description>Next generation sequencing-based shot-gun metagenomic test for the diagnosis of viral or bacterial infections using blood samples</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood and plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated with chemotherapy for Acute Leukaemia (AL) or Myelodysplastic Syndrome
        (MDS) or in the context of hematopoietic stem cell transplantation (HSCT), presenting a
        febrile neutropenic episode and suspected of infection
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 5 years and weight &gt; 16 Kg

          2. Patients having signed the written study informed consent form (ICF) prior to any
             study-mandated procedure. For children/adolescents: ICF obtained from both children's
             parents/ legal representative prior to any study-mandated procedure, and in addition
             for adolescents (13-17 years): assent form to be signed

          3. Patient presenting severe neutropenia (absolute neutrophil count &lt; 0.5 Giga/L)
             anticipated to be long lasting (&gt; 10 days) following intensive chemotherapy for acute
             myeloid or lymphoid leukaemia (AML or ALL) or myelodysplastic syndrome or in the
             context of hematopoietic stem cells transplantation

          4. Febrile episode (oral temperature &gt; 38.3°C once, or 2 measures &gt; 38.0°C taken 2h
             apart).

        Exclusion Criteria:

          1. Known HIV infection or AIDS diagnosis

          2. Already microbiologically confirmed infection

          3. Patient status preventing the study test to be performed

          4. Patient with an obvious infectious disease diagnosis requiring minimal additional
             microbiological documentation or confirmation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2017</study_first_submitted>
  <study_first_submitted_qc>December 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2017</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>metagenomic</keyword>
  <keyword>infection</keyword>
  <keyword>diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Neutropenia</mesh_term>
    <mesh_term>Fever</mesh_term>
    <mesh_term>Febrile Neutropenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

